Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Crohn Disease 5Lymphoma, Follicular 1Fistula 1Arthritis, Rheumatoid 1

Interventions

Methotrexate 4Abatacept 3tocilizumab 2olokizumab 2Rituximab 2tofacitinib 1secukinumab 1golimumab 1baricitinib 1Radioimmunodetection 1RC-18 1Etanercept 1Double-Blind Method 1Certolizumab Pegol 1Antirheumatic Agents 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Arthritis, Rheumatoid × Certolizumab Pegol × Clear all
NCT01374971 2014-04-08

Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)

Arthritis Treatment Center, Maryland

Phase 3 Completed
12 enrolled 4 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡